Welcome to our dedicated page for DXC Technology Co SEC filings (Ticker: DXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DXC Technology Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DXC Technology Co's regulatory disclosures and financial reporting.
August Raymond Alexander reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology executive Raymond Alexander, President of Insurance Software & BPS, reported an equity award of 43,814 shares of Common Stock. The grant consists of FY2024 performance-vesting restricted stock units (PSUs) earned over a three-year performance period and scheduled to settle on or around May 23, 2026. There was no purchase price, reflecting compensation rather than an open-market buy. After this award, Alexander directly holds 371,946 shares of Common Stock, which the disclosure notes includes unvested restricted stock units.
American Century entities reported beneficial ownership stakes in DXC Technology Company Common Stock. The filing lists holdings as of 03/31/2026, showing American Century ETF Trust with 8,706,339 shares (5.1%) and American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each with 9,074,619 shares (5.4%). The schedule identifies voting and dispositive power as sole for those holdings and states the filings were signed on 05/01/2026.
Vanguard Capital Management reported beneficial ownership of 8,883,306 shares of DXC Technology Co. The filing shows this equals 5.23% of the class and that Vanguard has sole dispositive power over 8,883,306 shares and sole voting power over 1,296,265 shares.
The filing is a Schedule 13G for Common Stock (CUSIP 23355L106) dated 03/31/2026 and signed on 04/29/2026. The report states holdings include shares held for Vanguard funds and managed accounts under Vanguard Capital Management and affiliated business divisions.
DXC Technology Co reported that Vanguard Portfolio Management beneficially owns 13,143,240 shares of common stock, representing 7.74% of the class. The filing shows sole dispositive power over 13,143,240 shares and sole voting power for 247,989 shares, per the Schedule 13G disclosure.
DXC Technology Co Schedule 13G: Glenview Capital Management and Larry Robbins report beneficial ownership of 8,895,875 shares of Common Stock, representing approximately 5.2% of the outstanding shares. Shares outstanding were 169,759,963 as of January 20, 2026.
The filing states the reported stake consists of 3,753,999 shares held for Glenview Capital Master Fund and 5,141,876 shares held for Glenview Offshore Opportunity Master Fund, with shared voting and dispositive power over the full amount.
DXC Technology Co received an amended Schedule 13G filing showing that The Vanguard Group reports zero shares beneficially owned of DXC Common Stock following an internal realignment effective January 12, 2026. The filing states Vanguard disaggregated certain subsidiaries and business divisions to report separately in reliance on SEC Release No. 34-39538.
The amendment is signed by Vanguard's Head of Global Fund Administration and records 0 shares (0%) beneficially owned as of the filing.
DXC Technology Co senior vice president and controller Christopher Anthony Voci reported a tax-withholding disposition of common stock tied to restricted stock unit vesting. On February 13, 2026, 5,399 shares at $13.39 were withheld to cover taxes generated by 10,889 RSUs vesting in the second of three annual installments. After this transaction, he directly beneficially owned 83,206 shares, and this amount includes unvested RSUs.
DXC Technology’s President and CEO, Raul J. Fernandez, reported an open‑market purchase of common stock. On 02/02/2026, he bought 16,446 shares of DXC common stock at a weighted average price of $15.2442 per share. After this transaction, he beneficially owned 816,001 shares directly, and this amount includes unvested restricted stock units.
DXC Technology reported quarterly revenue of $3.2 billion, down 1% year-over-year, as organic revenue declined but foreign exchange was favorable. Net income attributable to common stockholders rose to $107 million from $57 million, and diluted EPS increased to $0.61 from $0.31.
Cost discipline supported results: costs of services were roughly flat, while depreciation and amortization and restructuring costs declined, helping EBIT reach $179 million. Consulting & Engineering and Global Infrastructure Services saw modest revenue declines, while Insurance Services grew revenue 4.6% but with lower margins.
For the first nine months, DXC generated $1,009 million of operating cash flow and $603 million of free cash flow after $406 million of capital expenditures. The company refinanced €650 million of notes, reduced total debt to $3.6 billion, and repurchased 13.1 million shares for about $190 million.
DXC Technology Company filed a Form 8-K to report that it issued an earnings press release for its third quarter of fiscal 2026, covering the period ended December 31, 2025. The company also scheduled a conference call at 5:00 ET on January 29, 2026 to discuss the results.
The press release is furnished as Exhibit 99.1, and the information in this report is being provided under Item 2.02 on a "furnished" basis rather than being deemed "filed" under the securities laws.